Abstract
The data on SARS-CoV-2 (COVID-19) in South Africa shows seasonal transmission patterns to date, with the peaks having occurred in winter and summer since the out-breaks began. The transmission dynamics have mainly been driven by variations in environmental factors and virus evolution, and the two are at the center of driving the different waves of the disease. It is thus important to understand the role of seasonality in the transmission dynamics of COVID-19. In this paper a compartmental model with a time dependent transmission rate is formulated and the stabilities of the steady states analysed. We note that if R0 < 1, the disease-free equilibrium is globally asymptotically stable, and the disease completely dies out and when R0 > 1, the system admits a positive periodic solution, and the disease is uniformly or periodically persistent. The model is fitted to data on new cases in South Africa for the first four waves. The model results clearly indicate the need to consider seasonality in the transmission dynamics of COVID-19 and its importance in modelling fluctuations in the data for new cases. The potential impact of seasonality in the transmission patterns of COVID-19 and the public health implications are discussed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
